ELF · e.l.f. Beauty, Inc. · Stock research

Current Thesis

The bear point that anchored this name through June died in ten days. Between 2026-07-10 and 2026-07-17, five desks raised targets: Citi to $92, Raymond James to $87 (Strong Buy), JPMorgan $80→$94 (Overweight), UBS $60→$80, Canaccord $90→$97 (Buy). In early June the same tape read Piper $60→$50 and a Bernstein initiation at Market Perform $60. Consensus moved from roughly $78 — flat to spot — to near $90.

What changed is a second growth leg. E.l.f. Hair was announced 2026-06-15, hit TikTok Shop 06-16, target.com 06-24, and all Target doors 07-05 at $6–9 price points with Target as exclusive retail partner. Canaccord's store checks found the Gloss Mode Treatment Oil sold out on shelf and online inside weeks and put the franchise at $200M+ annualized.

The tape disagrees. Shares closed $72.25 on 2026-07-14, down from $76.42 on 07-03, drifting lower straight through the upgrade cluster. Analyst conviction is rising into a falling price, and the 2026-08-05 Q1 FY2027 print is where that gap closes in one direction or the other.

Bullish and bearish views on e.l.f. Beauty, Inc.

The model's bull view on e.l.f. Beauty, Inc. (ELF), in brief: Analyst upgrades clustered inside 8 days — Citi $92 (07-10), Raymond James $87 (07-14), JPMorgan $94 (07-16), UBS $80 (07-16), Canaccord $97 (07-17). The bear view: Price is fading the upgrades. $76.42 on 07-03 to $72.25 on 07-14 while five targets went up is distribution into good news. Institutions selling into sell-side enthusiasm is a specific, observable pattern, and it is what the tape currently shows. Earnings are going backwards. Q4… Both cases follow in full.

Bull Case

• Analyst upgrades clustered inside 8 days — Citi $92 (07-10), Raymond James $87 (07-14), JPMorgan $94 (07-16), UBS $80 (07-16), Canaccord $97 (07-17). Five desks marking up simultaneously after a June of cuts is the signature of a narrative turning before the print, not a lone bullish outlier.
• e.l.f. Hair scaled faster than any prior category extension — ~1,500 social mentions at >90% positive sentiment in the opening weeks per Mentionlytics, 5–7x the average new-brand launch, with sell-outs forcing restocks. A $6–9 haircare line inside every Target is a distribution channel the company already owns.
• Rhode is compounding — $212M cumulative in under three years on roughly ten SKUs, DTC-only until now; the autumn 2026 Sephora US/Canada rollout is an unmodeled channel step-up rather than a same-store growth assumption.
• Multiple already reset — FY2027 guidance of $3.27–3.32 EPS puts the stock near 22x forward at $72.25, against the 50–80x it carried through 2023–24. Downside from multiple compression alone is largely spent.
• Tariff drag is quantified and shrinking — FY2026 blended ~55%; the 170% China spike (2026-04-09 to 2026-05-13) already rolled back; FY2027 guidance assumes 35%, with a $1 price increase across brands offsetting the ~$50M annualized cost.

Bear Case

• Price is fading the upgrades. $76.42 on 07-03 to $72.25 on 07-14 while five targets went up is distribution into good news. Institutions selling into sell-side enthusiasm is a specific, observable pattern, and it is what the tape currently shows.
• Earnings are going backwards. Q4 FY2026 adjusted EPS $0.32 versus $0.78 a year earlier, adjusted EBITDA $59M versus $81M, a $49.4M GAAP loss. The +35% headline growth was acquisition arithmetic.
• Organic deceleration is guided, not feared. Ex-Rhode, FY2027 is guided to +12–14% against a prior cadence of 20–77%. The July target raises implicitly assume Hair plus Rhode more than offsets a core that is slowing.
• The structure is still lower highs — ~$218 (2024-06-27 all-time close) → $150.99 (52-week high) → $72.25. The June bounce off $48.82 has produced no confirmed higher high, and the stock sits below the $89.67 52-week average price.
• China concentration unresolved at just under 75% of production. Every US-China tariff headline re-prices the FY2027 margin bridge.
• Hair is unproven in dollars. Social sentiment and one sold-out SKU are not a P&L line. The first actual revenue disclosure for e.l.f. Hair arrives on 08-05, and the $200M estimate is an analyst model with one month of data behind it.

Setup & Price Structure

• Last close $72.25 (2026-07-14); 52-week band $48.82–$150.99; 52-week average $89.67; market cap ~$4.45B.
• The RSI-82 stretch flagged in early July has fully unwound. The stock gave back the $76.42 high and is retesting the $69.91 low printed 2026-06-29 — that pivot is now the entire structural question.
• $69.91 holding on a weekly basis builds the first higher low of the recovery and turns the June bounce into a base. Losing it re-opens the $48.82 low with no visible support between.
• Overhead supply sits $78–$90, exactly where the upgraded target cluster now lives. Any move needs to clear a shelf that has capped every rally since the April break.
• Location is better than it was two weeks ago — nearer the pivot, less extended, with the fundamental news flow improved. That is a pullback inside a downtrend, and it earns a probe rather than size until $69.91 proves itself or the print resolves it.

Catalyst Calendar (next 30 days)

• Ongoing through August — e.l.f. Hair sell-through data from Target doors (in all stores since 07-05); Nielsen/Circana mass-cosmetics share reads are the third-party check on whether the launch converts sentiment to units.
• Autumn 2026 (date unconfirmed) — Rhode enters Sephora US/Canada wholesale. Any firm date announced on the 08-05 call is itself a catalyst.

Elapsed catalysts

• 2026-07-31 (est.) — start of the practical earnings blackout window; entries after this date are pre-print gambles regardless of setup quality. (passed 9d ago)
• 2026-08-05, after close — Q1 FY2027 results and call. Consensus EPS ~$0.69. The three numbers that matter: standalone Rhode contribution, any first disclosure of e.l.f. Hair sell-through, and whether FY2027 organic guidance of +12–14% holds, is raised, or is cut. (passed 4d ago)

What Would Change Our Mind

• Bullish flip to a higher tier: an 08-05 print that raises FY2027 organic growth above the +12–14% guide, discloses e.l.f. Hair revenue tracking toward Canaccord's $200M run-rate, and is followed by a weekly close above $90 — clearing the analyst-target shelf on volume.
• Thesis break: a weekly close below $69 loses the 2026-06-29 pivot at $69.91 and invalidates the entire bounce structure. At that point the July upgrade cluster becomes a contrarian signal against the name.
• Slower disqualifier: guidance held flat or cut on 08-05 with no Hair revenue disclosure would confirm the desks marked up on sentiment data, and the $78–$90 supply zone stays unreachable into FY2027.
• Exogenous: renewed China tariff escalation above the 35% FY2027 assumption breaks the margin bridge independent of brand momentum.

Correlation Notes

• Trades with consumer-discretionary-rotation, currently maturing rather than accelerating — the cohort is not producing synchronized breakouts, so there is no cluster confirmation behind this name. It is moving on company-specific news.
• Beauty comps (ULTA, COTY, EL) provide the sector read; ELF's beta to them rises sharply around mass-cosmetics share data and falls around Rhode/Hair news, which is idiosyncratic.
• Celebrity-brand-halo exposure via Rhode ties a slice of the equity value to Hailey Bieber's personal brand — a correlation with no hedge and no warning period.
• Target (TGT) is now a genuine correlate through exclusive haircare distribution; Target traffic weakness would hit the Hair ramp directly.
• China tariff headlines move this name harder than most consumer staples given just-under-75% sourcing concentration. The stock trades as a partial tariff-policy proxy on those days.